Tenelia targets the top Januvia by effectiveness comparison

Movements of ‘Tenelia(generic name: teneligliptin),’ a DPP-4 inhibitor launched for the 7^th time in the domestic market, have been aggressive. Handok has stressed its goal to name the drug in the ‘Top 3’ by showing its indirect comparison result to ‘Januvia(generic name: sitagliptin).

The company announced that it has been conducting a clinical trial to directly compare its drug with Januvia a...